Surmodics, Inc. ã¯ãåäŒç€Ÿãšãšãã«ãç±³åœããã³æµ·å€ã§è¡ç®¡å
å»çæ©åšã®è¡šé¢æ¹è³ªæè¡ãäœå€èšºæå
ç«æž¬å®æ€æ»ããã³ãã€ã¯ãã¢ã¬ã€çšã®ååŠæåãæäŸããŠããŸããå瀟ã¯ãå»çæ©åšãšäœå€èšºæ (IVD) ã® 2 ã€ã®ã»ã°ã¡ã³ãã§äºæ¥ãå±éããŠããŸããå»çæ©åšã»ã°ã¡ã³ãã¯ãå»çæ©åšã®ã¢ã¯ã»ã¹ãééæ§ãããã³äºæž¬å¯èœãªé
眮ã匷åããè¡šé¢æ¹è³ªã³ãŒãã£ã³ã°æè¡ãããã³å ç¶åèãæ«æ¢¢ãç¥çµè¡ç®¡ãæ§é çå¿èãªã©ã®åžå Žåãã«å»çæ©åšã®è¡šé¢ããéšäœç¹ç°çãªè¬å€ééãæäŸããè¬å€ééã³ãŒãã£ã³ã°æè¡ã®æäŸã«åŸäºããŠããŸãããŸããæ«æ¢¢åèçŸæ£ã®æ²»çããã®ä»ã®çšéåãã®è¬å€ã³ãŒãã£ã³ã°ãã«ãŒã³ãå«ãããã«ãŒã³ãšã«ããŒãã«ãäžå¿ãšããä»å
¥å»çæ©åšã®èšèšãéçºã補é ãè¡ã£ãŠããŸããIVD ã»ã°ã¡ã³ãã¯ã蚺æå
ç«æž¬å®ãå忀æ»ãçç©å»åŠç ç©¶çšéåãã®ã³ã³ããŒãã³ã補åãšæè¡ãèšèšãéçºã補é ããŠããŸãããã®ã»ã°ã¡ã³ãã¯ãã¿ã³ãã¯è³ªå®å®å詊è¬ãåºè³ªã衚é¢ã³ãŒãã£ã³ã°ãããã³æåãæäŸããŠããŸããå瀟ã¯1979幎ã«èšç«ããããããœã¿å·ãšãã³ãã¬ãŒãªãŒã«æ¬ç€Ÿã眮ããŠããŸãã